“…In 2013, age restrictions were reduced to 16, and ECP was moved from behind the pharmacy counter to directly “on the shelf” (Guttmacher Institute, ). Despite the increased availability, barriers to access and use still exist, including cost, confidentiality, and incomplete and inaccurate information among potential users (Corbett et al., ; Hickey, ; Hickey & White, ; Johnson, Nshom, Nye, & Cohall, 2010; Kavanaugh, Williams, & Schwarz, ). Various researchers have noted that women do not obtain information on sexual and reproductive health, including ECP, from healthcare providers (Corbett et al., ; Hickey, ; Hickey & White, ; Kavanaugh et al., ; Moore & Smith, ).…”